A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta.
According to a briefing from the UK Health Security Agency, released on Friday, “a Delta sublineage newly designated as AY.4.2 is noted to be expanding in England”, with the body adding that the variant is being monitored and assessed.
The report states that in the week beginning 27 September – the last week for which complete sequencing data was available – AY.4.2 accounted for about 6% of sequenced coronavirus cases and is “on an increasing trajectory”.
AY.4.2 contains two mutations in its spike protein, called A222V and Y145H. The spike protein sits on the outside of the coronavirus and helps the virus to enter cells.
However, Ravi Gupta, a professor of clinical microbiology at the University of Cambridge, told the Guardian these mutations were not of particular concern. “A222V has been seen in other lineages of Delta,” he said. “It doesn’t have a really large effect on the virus.”
Gupta added similar mutations to Y145H had been seen in the Alpha variant and other variants. While these appear to have an effect on the binding between antibodies and the virus, Gupta said the effect was, at most, modest.
“But in my mind, these are not really significant mutations,” he said. “We need to look further at what the non-spike mutations are.”
In the past, new Covid variants have fuelled large surges in the number of cases – the Alpha variant played a key role in rising cases last winter, while the Delta variant took off and led to sharp increases in the spring. Daily Covid cases in England are rising once again: 39,624 new Covid cases were reported on Saturday, the highest figure since late July.
According to the Financial Times, Dr Jeffrey Barrett, the director of the Covid-19 Genomics Initiative at the Wellcome Sanger Institute in Cambridge, and Prof Francois Balloux, the director of the University College London Genetics Institute, have suggested AY.4.2 could be 10-15% more transmissible than the original Delta variant.
However, they urged caution. “Britain is the only country in which it has taken off in this way and I still would not rule out its growth being a chance demographic event,” Balloux told the FT.
Balloux told the Guardian the new variant was unlikely to be behind the recent rise in cases.
“Its potential higher transmissibility could at this stage only explain a tiny fraction of additional cases,” he said. “It’s around 10% frequency [now], and assuming it may be 10% more transmissible, that would only explain an additional 1% extra infections [every five or so days].”
Gupta said the focus on a new variant was missing the point, noting a number of other important factors including the slow rollout of jabs to older children. According to official figures, vaccination rates among 12- to 15-year-olds were about three times lower in England than Scotland.
“We shouldn’t be blaming the virus for what is going on in the UK,” said Gupta. “It is because we have fundamentally failed to control transmission, and that is because kids are vulnerable, they have not been vaccinated, they are back at school, they are spreading virus among themselves and they are feeding it into their families.”
News
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]















